SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-029018
Filing Date
2020-06-11
Accepted
2020-06-11 16:15:39
Documents
2
Period of Report
2020-06-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 KALV-2020-06-11-8-K kalv-8k_20200611.htm 8-K 37186
2 EX-3.1 kalv-ex31_6.htm EX-3.1 3010
  Complete submission text file 0001564590-20-029018.txt   41677
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-36830 | Film No.: 20957341
SIC: 2834 Pharmaceutical Preparations